Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|1||NCT03206203||Recruiting||Carboplatin With or Without Atezolizumab in Treating Patients With Stage IV Triple Negative Breast Cancer||
||Other / NIH / Industry||
||185||All||18 Years and older (Adult, Older Adult)||NCT03206203||VICC BRE 15136
|July 27, 2017||February 2020||February 2022||July 2, 2017||October 9, 2018||